Annexon (ANNX) Change in Account Payables (2019 - 2026)
Annexon (ANNX) posted quarterly Change in Account Payables of $2.2 million for Q1 2026, up 7038.71% year-over-year from $30131.5 in Q1 2025, and up 165.88% quarter-over-quarter from -$3.3 million in Q4 2025.
Annexon (ANNX) Change in Account Payables (2019 - 2026) Analysis & Trends
Annexon's Change in Account Payables history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 7038.71% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $6.7 million (up 3.68% YoY), while the FY2025 annual figure was $4.5 million, down 9.02% from the prior year.
- Change in Account Payables for Q1 2026 stood at $2.2 million, up from -$3.3 million in the prior quarter.
- The five-year high for Change in Account Payables was $6.7 million in Q3 2025, with the low at -$3.4 million in Q3 2022.
- The 5-year median for Change in Account Payables is $490000.0 (2022), against an average of $542000.0.
- The sharpest annual moves came in 2022 and 2026: Change in Account Payables tumbled 514.18% in 2022, then soared 7038.71% in 2026.
- Annexon's Change in Account Payables stood at $490000.0 in 2022, then slipped by 13.06% to $426000.0 in 2023, then jumped by 765.96% to $3.7 million in 2024, then plunged by 188.51% to -$3.3 million in 2025, then jumped by 165.88% to $2.2 million in 2026.
- Business Quant data shows ANNX's Change in Account Payables at $2.2 million in Q1 2026, -$3.3 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Annexon | 1.00 Bn | 1.00 Bn | - | -1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.36 Mn |
| Jun 30, 2026 | -1.36 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 3.69 Mn |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | -1.53 Mn |
| Mar 31, 2024 | -1.53 Mn |